Thomas A - Search Results

1

Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with Cancer.

Liu C, Shatila M, Mathew A, Machado AP, Thomas A, Zhang HC, Thomas AS, Faleck D, Funchain P, Philpott J, Grivas P, Obeid M, Carbonnel F, Wang Y. Liu C, et al. Among authors: thomas as, thomas a. J Cancer. 2023 Jun 26;14(10):1913-1919. doi: 10.7150/jca.84261. eCollection 2023. J Cancer. 2023. PMID: 37476185 Free PMC article.

2

An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis With Uncertain Etiology in the Context of Chronic Myeloid Leukemia.

Peng Y, Thomas AS, Wei D, Tan D, Wang Y. Peng Y, et al. Inflamm Bowel Dis. 2020 Mar 4;26(4):e26-e27. doi: 10.1093/ibd/izaa016. Inflamm Bowel Dis. 2020. PMID: 32016290 No abstract available.

3

Checkpoint Inhibitor-Induced Colitis.

Thomas AS, Wang Y. Thomas AS, et al. Am J Gastroenterol. 2020 Aug;115(8):1301-1302. doi: 10.14309/ajg.0000000000000739. Am J Gastroenterol. 2020. PMID: 32756260 No abstract available.

4

Management of Immune-Related Colitis During the COVID-19 Pandemic.

Amin R, Thomas AS, Khurana S, Panneerselvam K, Zou F, Ma W, Chari ST, Wang Y. Amin R, et al. Inflamm Bowel Dis. 2020 Sep 18;26(10):e110-e111. doi: 10.1093/ibd/izaa235. Inflamm Bowel Dis. 2020. PMID: 32812047 Free PMC article. No abstract available.

5

Association of Chronic Immune-Mediated Diarrhea and Colitis With Favorable Cancer Response.

Zou F, Abu-Sbeih H, Ma W, Peng Y, Qiao W, Wang J, Shah AY, Glitza Oliva IC, Piha-Paul SA, Thompson JA, Zhang HC, Thomas AS, Wang Y. Zou F, et al. Among authors: thomas as. J Natl Compr Canc Netw. 2020 Dec 14;19(6):700-708. doi: 10.6004/jnccn.2020.7647. J Natl Compr Canc Netw. 2020. PMID: 33316767

6

Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis.

Zou F, Wang X, Glitza Oliva IC, McQuade JL, Wang J, Zhang HC, Thompson JA, Thomas AS, Wang Y. Zou F, et al. Among authors: thomas as. J Immunother Cancer. 2021 Jan;9(1):e002058. doi: 10.1136/jitc-2020-002058. J Immunother Cancer. 2021. PMID: 33436487 Free PMC article.

7

Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors.

Thomas AS, Ma W, Wang Y. Thomas AS, et al. N Engl J Med. 2021 Feb 11;384(6):581-583. doi: 10.1056/NEJMc2031717. N Engl J Med. 2021. PMID: 33567198 No abstract available.

8

Clinical Characteristics and Outcomes of Eosinophilic Colitis in Patients With Cancer.

Khurana S, Abu-Sbeih H, Ma W, Qiao W, Foo WC, Richards DM, Thomas AS, Khan A, Zhang HC, Wang Y. Khurana S, et al. Among authors: thomas as. Am J Clin Oncol. 2021 Aug 1;44(8):395-401. doi: 10.1097/COC.0000000000000838. Am J Clin Oncol. 2021. PMID: 34091476

9

Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related Esophagitis.

Panneerselvam K, Amin RN, Wei D, Tan D, Lum PJ, Zhang HC, Richards DM, Altan M, Grivas P, Thompson JA, Thomas AS, Wang Y. Panneerselvam K, et al. Among authors: thomas as. J Natl Compr Canc Netw. 2021 Jun 11;19(8):896-904. doi: 10.6004/jnccn.2020.7675. J Natl Compr Canc Netw. 2021. PMID: 34102607

10

Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections.

Ma W, Gong Z, Abu-Sbeih H, Peng Y, Peng F, Zou F, Charabaty A, Okhuysen PC, McQuade JL, Altan M, Zhang HC, Thomas AS, Wang Y. Ma W, et al. Among authors: thomas as. Am J Clin Oncol. 2021 Aug 1;44(8):402-408. doi: 10.1097/COC.0000000000000841. Am J Clin Oncol. 2021. PMID: 34107499

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,641 results

Search Page